Medicine guide

ANZUPGO

As listed in the register: ANZUPGO 20 mg/g, crème

20 mg · crème

  • Prescription only
Active substance
Delgocitinib
Made by
LEO PHARMA A/S (DANEMARK)

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

Details

Made byLEO PHARMA A/S (DANEMARK)
Active substanceDelgocitinib
Strength20 mg
Formcrème
Routecutanée
Dispensing (as stated by the register)médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux spécialistes et services DERMATOLOGIE · liste I · prescription réservée aux spécialistes et services ALLERGOLOGIE
MarketedYes, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/24/1851
Name in the registerANZUPGO 20 mg/g, crème
Packs1 tube(s) laminé polyéthylène basse densité (PEBD) de 60 g
CIS61015604
CIP133400930303092

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).